Adaptive enrichment designs involve preplanned rules for modifying enrollment criteria based on accruing data in a randomized trial. We focus on designs where the overall population is partitioned into two predefined subpopulations, e.g., based on a biomarker or risk score measured at baseline. The goal is to learn which populations benefit from an experimental treatment. Two critical components of adaptive enrichment designs are the decision rule for modifying enrollment, and the multiple testing procedure. We provide a general method for simultaneously optimizing these components for two stage, adaptive enrichment designs. We minimize the expected sample size under constraints on power and the familywise Type I error rate. It is computati...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
We propose and evaluate a two-stage, phase 2, adaptive clinical trial design. Its goal is to determi...
An adaptive enrichment design is a randomized trial that allows enrollment criteria to be modified a...
We consider the problem of designing a randomized trial for comparing two treatments versus a common...
We propose new, optimal methods for analyzing randomized trials, when it is suspected that treatment...
Based on a Bayesian decision theoretic approach, we optimize frequentist single- and adaptive two-st...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
We propose new, optimal methods for analyzing randomized trials, when it is sus-pected that treatmen...
We propose new, optimal methods for analyzing randomized trials, when it is suspected that treatment...
Based on a Bayesian decision theoretic approach, we optimize frequentist single- and adaptive two-st...
Prior work has shown that certain types of adaptive designs can always be dominated by a suitably ch...
It is a challenge to evaluate experimental treatments where it is suspected that the treatment effec...
Adaptive enrichment designs involve preplanned rules for modifying enrollment criteria based on accr...
Adaptive enrichment designs involve preplanned rules for modifying patient enrollment criteria based...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
We propose and evaluate a two-stage, phase 2, adaptive clinical trial design. Its goal is to determi...
An adaptive enrichment design is a randomized trial that allows enrollment criteria to be modified a...
We consider the problem of designing a randomized trial for comparing two treatments versus a common...
We propose new, optimal methods for analyzing randomized trials, when it is suspected that treatment...
Based on a Bayesian decision theoretic approach, we optimize frequentist single- and adaptive two-st...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
We propose new, optimal methods for analyzing randomized trials, when it is sus-pected that treatmen...
We propose new, optimal methods for analyzing randomized trials, when it is suspected that treatment...
Based on a Bayesian decision theoretic approach, we optimize frequentist single- and adaptive two-st...
Prior work has shown that certain types of adaptive designs can always be dominated by a suitably ch...
It is a challenge to evaluate experimental treatments where it is suspected that the treatment effec...
Adaptive enrichment designs involve preplanned rules for modifying enrollment criteria based on accr...
Adaptive enrichment designs involve preplanned rules for modifying patient enrollment criteria based...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
Standard randomized trials may have lower than desired power when the treatment effect is only stron...
We propose and evaluate a two-stage, phase 2, adaptive clinical trial design. Its goal is to determi...